Facebook
Twitter
LinkedIn
Forward
The AHRQ Safety Program for Improving Antibiotic Use
The AHRQ Safety Program for Improving Antibiotic Use course is to develop and implement a bundle of technical and adaptive interventions designed to improve the use of antibiotics across acute care, long-term care, and ambulatory care facilities throughout the United States.
The Society for Healthcare Epidemiology of America will be providing Continueing Medical Education Credits to physicians for these educational webinars upon completion of the online evaluation.
Please select the “Register/Take Course” tab at the top and select to login or register.
- If you are a SHEA Member, please use your membership login to complete the evaluation.
- If you are not a SHEA Member, please select the link “Register New User”. The system will generate your username with your email address and ask you to set up your password. This will allow you to access to complete your evaluation and view your educational transcript at any time. Once you have created a password, you will be directed to your SHEA profile. Please revisit the evaluation page to complete your login and apply your access code.
In accordance with the Accreditation Council for Continuing Medical Educations (ACCME) Standards for Commercial Support for Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months relevant to the content presented. The Society for Healthcare Epidemiology of America (SHEA) identifies and manages all conflicts of interest prior to delivering the educational activity to learners.
Target Audience
Antibiotic Stewardship Physicians, Infectious Disease Physicians, and Frontline Prescribers
Learning Objectives
- Implement effective and sustainable antibiotic stewardship programs in your facility
- Review how to communicate effectively with other health care providers about antibiotic prescribing
- Discuss how to work as a team to incorporate the four moments of antibiotic decision-making into your antibiotic prescribing practices
| Planning Committee | Reviewers |
Adrian Alday, BS Genet Azang-Njaah, PharmD Lucas Bryk, PharmD Sara Cosgrove, MS, MS Bryna Ewachiw, PharmD, BCOP Denise Fu, PharmD Chris Heidenrich, MA Suanne Goldberger, RPH Jennifer Katzianer, PharmD Nicole Kiehle, PharmD Steven McMahan, RPH Melissa A. Miller, BSN, MD, MS Umbreen Murtaza, PharmD Amy Nathanson, PharmD Carlie Ockuly, PharmD, BCPS Melinda Ortmann, PharmD Tameika Reynaud, PharmD, MPH Lois Ann Reynolds, PharmD Ownership Interest: Johnson and Johnson Stock; Merck and Company Stock; Pfizer Stock Kathleen Speck, MPH Pranita Tamma, MD, MHS Laura Wachter, PharmD Cathy L. Walker, RPH Meghan Walrath Vivian A. Ukegbu, PharmD | Ann Fisher, MD Cindy Prins, PhD, MPH Marci Drees, MD, MS
Speakers Sara Cosgrove, MS, MS Pranita Tamma, MD, MHS |
Successful Completion Statement
Available Credit
- 15.00 AMA PRA Category 1 Credit™